CRYOPORT, INC. Preferred Stock Dividends, Income Statement Impact
CRYOPORT, INC. (CYRX) reported Preferred Stock Dividends, Income Statement Impact of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2018-03-08
- CRYOPORT, INC. preferred stock dividends, income statement impact for the quarter ending 2017-12-31 was $0.00.
- CRYOPORT, INC. preferred stock dividends, income statement impact for the quarter ending 2017-09-30 was $0.00.
- CRYOPORT, INC. preferred stock dividends, income statement impact for the quarter ending 2017-06-30 was $0.00.
- CRYOPORT, INC. preferred stock dividends, income statement impact for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. preferred stock dividends, income statement impact for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CRYOPORT, INC. preferred stock dividends, income statement impact for fiscal 2016 was $75.46K.
- CRYOPORT, INC. preferred stock dividends, income statement impact for fiscal 2016 was $762.73K, a 149.81% increase from fiscal 2015.
- CRYOPORT, INC. preferred stock dividends, income statement impact for fiscal 2015 was $305.33K.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-08 | $0.00 derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-08 | $0.00 derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 | $75.46K 10-K · filed 2018-03-08 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 10-Q · filed 2016-11-14 | $75.46K 10-Q · filed 2017-11-02 | $314.85K derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $75.46K 10-Q · filed 2017-08-09 | $314.85K derived: sum of 3 quarters · filed 2017-08-09 | $554.24K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $75.46K 10-Q · filed 2017-05-04 | $314.85K derived: sum of 2 quarters · filed 2017-05-04 | $554.24K derived: sum of 3 quarters · filed 2017-05-04 | $762.73K 10-KT · filed 2017-03-13 |
| 2015-12-31 | $239.39K 10-Q · filed 2016-02-11 | $478.78K derived: sum of 2 quarters · filed 2016-11-14 | $687.27K 10-KT · filed 2017-03-13 | $797.69K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-09-30 | $239.39K 10-Q · filed 2016-11-14 | $447.88K 10-Q · filed 2016-11-14 | $558.30K derived: sum of 3 quarters · filed 2016-11-14 | $653.61K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $208.49K 10-Q · filed 2016-08-15 | $318.92K derived: sum of 2 quarters · filed 2016-08-15 | $414.22K derived: sum of 3 quarters · filed 2016-08-15 | $486.10K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $110.43K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28 | $205.73K derived: sum of 2 quarters · filed 2016-06-28 | $277.61K derived: sum of 3 quarters · filed 2016-06-28 | $305.33K 10-K · filed 2016-06-28 |
| 2014-12-31 | $95.30K 10-Q · filed 2016-02-11 | $167.18K derived: sum of 2 quarters · filed 2016-02-11 | $194.90K 10-Q · filed 2016-02-11 | $194.90K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-09-30 | $71.87K 10-Q · filed 2015-11-16 | $99.60K 10-Q · filed 2015-11-16 | $99.60K derived: sum of 3 quarters · filed 2015-11-16 | $99.60K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $27.72K 10-Q · filed 2015-08-06 | $27.72K derived: sum of 2 quarters · filed 2015-08-06 | $27.72K derived: sum of 3 quarters · filed 2015-08-06 | $27.72K derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $0.00 derived: sum of 2 quarters · filed 2015-05-19 | $0.00 derived: sum of 3 quarters · filed 2015-05-19 | $0.00 10-K · filed 2015-05-19 |
| 2013-12-31 | $0.00 10-Q · filed 2015-02-05 | $0.00 derived: sum of 2 quarters · filed 2015-02-05 | $0.00 10-Q · filed 2015-02-05 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |